ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-OR56

Quantitative Characterization of Nonsclerotic Glomeruli Is Prognostic of Clinical Outcomes in Proteinuric Diseases

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Ambekar, Akhil, Department of Pathology, Division of AI & Computational Pathology, Duke University, Durham, North Carolina, United States
  • Liu, Qian, Children’s Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, United States
  • Zee, Jarcy, Children’s Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, United States
  • Wang, Bangchen, Department of Pathology, Division of AI & Computational Pathology, Duke University, Durham, North Carolina, United States
  • Cassol, Clarissa Araujo, Arkana Laboratories, Little Rock, Arkansas, United States
  • Mariani, Laura H., Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States
  • Holzman, Lawrence B., Department of Medicine, Division of Nephrology and Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Hodgin, Jeffrey B., Department of Pathology, University of Michigan, Ann Arbor, Michigan, United States
  • Madabhushi, Anant, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, United States
  • Lafata, Kyle Jon, Department of Radiation Oncology, Duke University, Durham, North Carolina, United States
  • Barisoni, Laura, Department of Pathology, Division of AI & Computational Pathology, Duke University, Durham, North Carolina, United States
  • Janowczyk, Andrew, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, United States
Background

Visual assessment of segmentally (SS), globally (GS) and non-GS/SS glomeruli is used clinically for the diagnosis and prognostication of glomerular diseases. We hypothesized that encoded in non-GS/SS glomeruli are computationally derivable subvisual features prognostic of outcome.

Methods

N=186 (99 MCD/MCD-like, 87 FSGS) patients from the NEPTUNE/CureGN cohorts with at least one PAS whole slide image (WSI) containing 4 non-GS/SS glomeruli were included. A previously validated pipeline for glomerular segmentation and classification was applied to WSIs, yielding 272 GS, 113 SS, and 2661 non-GS/SS glomeruli. Percent of SS and GS was calculated. From non-GS/SS glomeruli, 108 intensity, shape, and texture features were computed. Patient-level summary statistics were produced using mean, standard deviation, kurtosis, minimum, maximum, and median. Maximum Relevance Minimum Redundancy (MRMR) selected the 10 most prognostic features for time from biopsy to disease progression (≥40% eGFR decline with last eGFR<90 or kidney failure), and to first complete proteinuria remission (UPCR<0.3). Ridge regression models estimated prognostic accuracy of non-GS/SS glomerular features.

Results

Prognostic features (Table 1) reflect the heterogeneity of intra-glomerular organization. These features were the most prognostic of disease progression compared to other models and increased the prognostic accuracy of both clinical outcomes when added to conventional parameters (Table 2).

Conclusion

Computational methods allow for extraction from non-GS/SS glomeruli of information prognostic of clinical outcomes above and beyond conventional methods. This novel approach may enable early diagnosis and facilitate risk-stratification independently from the presence of conventional diagnostic lesions of sclerosis.

Funding

  • NIDDK Support